Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placenta-Derived MSC Secretome for Acute GvHD
NCT06469411Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jan 2023
- Primary completion
- Jun 2023
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in Acute Graft-Versus-Host Disease (aGvHD) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Liver involvement, Intestine condition and 1 more. Started Jan 2023; status: completed.
02
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT06469411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06469411.